Valneva Aktie
| 9,88EUR | 0,03EUR | 0,30% |
WKN DE: A0MVJZ / ISIN: FR0004056851
Aktionärsstruktur
| Inhaber | in % |
|---|---|
| Freefloat | 69,23 |
| Bpifrance Participations SA /PRIVATE EQUITY/ | 7,35 |
| Polar Capital LLP | 3,91 |
| Polar Capital Funds Plc - Biotechnology Fund | 2,34 |
| CDC Croissance SA | 1,03 |
| Grimaud Family | 0,60 |
| LSP Life Sciences Fund NV | 0,59 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 457 | 0 | 0 | 0 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,23 | 0,00 | 0,00 | 0,00 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 83 | 126 | 129 | 308 | 586 |
| Summe Anlagevermögen | 164 | 201 | 220 | 183 | 285 |
| Summe Aktiva | 189 | 240 | 274 | 460 | 826 |
Bilanz (in Mio. EUR) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Gesamtverschuldung/ -verbindlichkeiten | 71 | 58 | 85 | 105 | 115 |
| Summe Fremdkapital | 97 | 97 | 139 | 382 | 655 |
| Summe Eigenkapital | 93 | 143 | 135 | 77 | 171 |
| Summe Passiva | 189 | 240 | 274 | 460 | 826 |
Adresse
| Campus Bio-Ouest, 44800 Saint-Herblain | |
| Telefon | +33 (2) 28-07-37-10 |
| Internet | http://www.valneva.com |
Management
|
Andreas Meinke
VP-Preclinical & Translational Research |
|
Anne-Marie Graffin
Member-Supervisory Board |
|
Franck Charles Marie Grimaud
Director General & Chief Business Officer |
|
Frédéric Grimaud
Chairman-Supervisory Board |
|
Frédéric Jacotot
Secretary & General Counsel |
|
Gerald Strohmaier
Head-Human Resources |
|
James E. Connolly
Member-Supervisory Board |
|
James R. Sulat
Vice Chairman-Supervisory Board |
|
Jason Golan
Vice President-Commercial Operations |
|
Johanna Willemina Pattenier
Member-Supervisory Board |
|
Juan Carlos Jaramillo
Chief Medical Officer |
|
Klaus Schwamborn
Vice President-Discovery Research & Innovation |
|
Laetitia Bachelot-Fontaine
Head-Investor Relations & Corporate Communications |
|
Manfred Tiefenbacher
Vice President-Finance |
|
Maïlys Ferrère
Member-Supervisory Board |
|
Michael Möhlen
Vice President-Technical Development |
|
Olivier Jankowitsch
Vice President-Global Supply Operations |
|
Perry Denis Celentano
Chief Operating Officer |
|
Peter Buhler
Chief Financial Officer |
|
Sharon E. Tetlow
Member-Supervisory Board |
|
Thomas Lingelbach
President & Chief Executive Officer |
|
Vincent Dequenne
Senior Vice President-Operations |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
